Used in peptide synthesis as a protected chiral building block, particularly in the development of complex organic molecules and pharmaceuticals. Its structure incorporates a fluorenylmethyloxycarbonyl (Fmoc) protecting group, making it compatible with solid-phase peptide synthesis (SPPS). The rigid polycyclic framework provides stereochemical control, enabling selective formation of peptide bonds and facilitating the construction of structurally defined peptides. Commonly employed in research settings for synthesizing bioactive compounds, especially those targeting neurological and enzymatic pathways.